Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
Leiden Bio Science Park welcomed His Royal Highness Prince Constantijn of the Netherlands for a visit that underscored the park’s role as a global hub for biotech innovation. Accompanied by Leiden University Chair Annetje Ottow, he met with key figures in the ecosystem, including Anouschka Versleijen and Diederik Engbersen, to discuss the challenges and opportunities surrounding academic spin-outs and startup growth.
At Mimetas, a leader in organ-on-a-chip and 3D disease modeling technology, the prince received an in-depth demonstration and engaged in discussions about securing funding for global expansion. The conversation highlighted the critical role of Leiden’s ecosystem in supporting biotech companies as they scale, emphasizing the importance of investment, collaboration, and streamlined innovation pathways.
Several startups shared their founder journeys, providing insight into their groundbreaking work and the hurdles they face. Among them were VitroScan, which is pioneering a drug response platform, Onnes Technologies, specializing in cryogenic nanopositioning, QuantaMap, advancing quantum sensor technology, Secuped, developing medical devices for diabetes, and AVIGI Therapeutics, working on new approaches to combat metastatic cancer.
Throughout the discussions, founders and industry leaders pointed to key issues affecting biotech entrepreneurship. While Leiden Bio Science Park is recognized as an excellent environment for startups, with strong shared facilities and an increasingly supportive infrastructure, challenges remain. The slow pace of contracting processes, limited access to biostatistics expertise, and the need for more targeted support in clinical trial management, go-to-market strategies, and certification were highlighted as areas for improvement. Entrepreneurs also stressed the gap in biotech seed funding, despite the availability of early-stage grants. Financial stability declarations required for many grant applications pose a particular challenge for deeptech startups, creating an additional barrier to securing essential resources.
Prince Constantijn’s visit reinforced Leiden Bio Science Park’s position as a key player in Europe’s biotech landscape. As the ecosystem continues to evolve, his discussions with founders and stakeholders underscored the importance of agility, investment, and policy refinements to ensure that innovation can thrive.
A new research collaboration between TNO, Logick Energetics B.V., and InnoSer has officially kicked off at Leiden Bio Science Park, supported by a TKI-LSH grant. The partners...
The Faculty of Science at Leiden University is offering a new opportunity for professionals to deepen their knowledge of data-driven decision-making, complex systems, and...
𝗪𝗵𝗮𝘁 𝗵𝗮𝗽𝗽𝗲𝗻𝘀 𝘄𝗵𝗲𝗻 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝟭𝟱 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗮𝗻𝗱 𝗯𝗶𝗼𝘁𝗲𝗰𝗵 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗮𝘁𝗶𝗼𝗻𝘀 𝗼𝗽𝗲𝗻 𝘁𝗵𝗲𝗶𝗿 𝗱𝗼𝗼𝗿𝘀 𝘁𝗼 𝘁𝗵𝗲 𝗽𝘂𝗯𝗹𝗶𝗰? You get an Open Day that brings together over 2,400 visitors, families, students,...